Ticker > Company >

Indraprastha Medical share price

Indraprastha Medical Corporation Ltd.

NSE: INDRAMEDCO BSE: 532150 SECTOR: Hospital & Healthcare Services  1.36 L   481   75

500.30
-5.70 (-1.13%)
BSE: 11 Sep 04:01 PM

Price Summary

Today's High

₹ 522

Today's Low

₹ 498

52 Week High

₹ 571.95

52 Week Low

₹ 307.9

FinStar

Ownership Stable
Ownership strength is slightly missing the benchmark.
ValuationFair
The stock’s market price justifies its intrinsic value.
EfficiencyExcellent
The company knows very well the utilization of its assets.
FinancialsVery Stable
The company possesses stable growth history and manageable debt.
*It is just an analytical rating of the company and not an investment advice.

Company Essentials

Market Cap

4586.4 Cr.

Enterprise Value

4264.65 Cr.

No. of Shares

9.17 Cr.

P/E

27.35

P/B

7.08

Face Value

₹ 10

Div. Yield

0.9 %

Book Value (TTM)

₹  70.7

CASH

321.75 Cr.

DEBT

0 Cr.

Promoter Holding

51 %

EPS (TTM)

₹  18.29

Sales Growth

8.97%

ROE

29.97 %

ROCE

41.43%

Profit Growth

29.87 %

* Total debt includes long term borrowing, short term borrowing plus current maturities of long-term borrowing
* Ratios are based on latest Audited Financial Result.

Your Added Ratios

Please login to Add & View your own added ratios.

Login

Brands

These are the brands of Indraprastha Medical Corporation Ltd.

Apollo hospitals

Price Chart 1d 1w 1m 3m 6m 1Yr 3Yr 5Yr

 

Volume Chart 1d 1w 1m 3m 6m 1Yr 3Yr 5Yr

* Prices are based on daily market changes.
* The chart is based on the standalone earnings of the company. * Negative values and values more than 1000x in PE chart is considered 0.

Peer Comparison

View Full Peer Comparison
* The Peers list includes companies operating in the same industry and having comparable market cap.

 Group Companies

Track the companies of Group.

Ratios

Sales Growth

1 Year8.97%
3 Year15.16%
5 Year10.3%

Profit Growth

1 Year29.87%
3 Year40.04%
5 Year29.84%

ROE%

1 Year29.97%
3 Year27.78%
5 Year20.76%

ROCE %

1 Year41.43%
3 Year38.53%
5 Year29.2%

Debt/Equity

0

Price to Cash Flow

29.26

Interest Cover Ratio

35.5008

CFO/PAT (5 Yr. Avg.)

1.4407591713922

Shareholding Pattern

Promoter Pledging %

Date Promoter % Pledge %
Jun 2025 51.00 0.00
Mar 2025 51.00 0.00
Dec 2024 51.00 0.00
Sep 2024 51.00 0.00
Jun 2024 51.00 0.00
Investors List
* Figures given above are % of equity capital

 Strengths

  • The company has shown a good profit growth of 40.039653899799% for the Past 3 years.
  • The company has shown a good revenue growth of 15.1579632100015% for the Past 3 years.
  • Company has been maintaining healthy ROE of 27.7774666666667% over the past 3 years.
  • Company has been maintaining healthy ROCE of 38.533% over the past 3 years.
  • Company is virtually debt free.
  • Company has a healthy Interest coverage ratio of 35.5008.
  • Company’s PEG ratio is 0.915621962585821.
  • The company has an efficient Cash Conversion Cycle of 19.9634 days.
  • Company has a healthy liquidity position with current ratio of 2.4125.
  • The company has a good cash flow management; CFO/PAT stands at 1.4407591713922.
  • The company has a high promoter holding of 51%.

 Limitations

 Looks like the company does not have any serious limitations.

Quarterly Result (All Figures in Cr.)

PARTICULARS Jun 2024 Sep 2024 Dec 2024 Mar 2025 Jun 2025
Net Sales 347.86 349.82 324.93 333.75 365.06
Total Expenditure 280.74 286.18 272.74 272.43 291.91
Operating Profit 67.12 63.64 52.19 61.32 73.15
Other Income 5.12 6.05 5.13 6.35 6.9
Interest 1.61 1.59 1.58 1.49 1.56
Depreciation 11.04 11.17 11.21 10.91 10.18
Exceptional Items 0 0 0 0 0
Profit Before Tax 59.59 56.93 44.53 55.27 68.31
Tax 14.82 14.53 11.72 14.26 16.85
Profit After Tax 44.77 42.4 32.81 41.01 51.46
Adjusted EPS (Rs) 4.88 4.63 3.58 4.47 5.61

Profit & Loss (All Figures in Cr. Adjusted EPS in Rs.)

PARTICULARS Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Net Sales 613.38 888.16 1098.67 1244.7 1356.36
Total Expenditure 573.11 773.86 947.97 1051.34 1112.09
Operating Profit 40.27 114.3 150.7 193.36 244.27
Other Income 0.68 3.12 10.03 16.89 22.65
Interest 3.34 3.41 4.28 4.06 6.27
Depreciation 33.32 34.94 39.27 40.08 44.33
Exceptional Items 0 0 0 0 0
Profit Before Tax 4.29 79.07 117.18 166.11 216.32
Tax 1.96 20.45 31.03 42.15 55.33
Net Profit 2.33 58.62 86.15 123.96 160.99
Adjusted EPS (Rs.) 0.25 6.39 9.4 13.52 17.56

Balance Sheet (All Figures are in Crores.)

Particulars Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Equity and Liabilities
Share Capital 91.67 91.67 91.67 91.67 91.67
Total Reserves 181.08 233.77 287.78 386.09 505.01
Borrowings 0 0 0 0 0
Other N/C liabilities 43.3 42.77 46.06 80.06 76.23
Current liabilities 115.9 93.5 129.63 165.42 178.71
Total Liabilities 431.95 461.71 555.14 723.24 851.62
Assets
Net Block 283.33 276.86 275.05 346.94 328.06
Capital WIP 3.33 0 2.53 0.47 32.52
Intangible WIP 0 0 0 0 0
Investments 0 0 0 0 0
Loans & Advances 3.82 4.4 8.16 6.27 4.42
Other N/C Assets 0.04 23.02 46.32 61.58 55.49
Current Assets 141.43 157.43 223.08 307.98 431.13
Total Assets 431.95 461.71 555.14 723.24 851.62
* Other Non-current Liabilities include Net deferred Liabilities

Cash Flows (All Figures are in Crores.)

PARTICULARS Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Profit from operations 4.29 79.07 117.18 166.11 216.32
Adjustment 34.16 38.2 30.57 25.42 25.22
Changes in Assets & Liabilities -2.27 -3.45 6.66 55.46 -23.8
Tax Paid -9.37 -19.51 -9.85 -46.83 -60.98
Operating Cash Flow 26.81 94.3 144.47 200.15 156.75
Investing Cash Flow -19.08 -74.11 -107.91 -158.43 -110.99
Financing Cash Flow -3.14 -3.37 -26.04 -32.38 -45.88
Net Cash Flow 4.59 16.82 10.52 9.34 -0.12

Corporate Actions

Investors Details

PARTICULARS Jun 2024% Sep 2024% Dec 2024% Mar 2025% Jun 2025%
promoters 51.00 51.00 51.00 51.00 51.00
apollo hospitals enterpri... - - 22.02 22.02 22.02
pcr investments limited 0.42 0.42 0.42 0.42 0.42
prathap c reddy 0.26 0.26 0.26 0.26 0.26
preetha reddy 0.22 0.22 0.22 0.22 0.22
president of india - 26.00 26.00 26.00 26.00
sangita reddy 0.01 0.01 0.01 0.01 0.01
shobhana kamineni - - 0.13 0.13 0.13
sucharitha p reddy 0.18 0.18 0.18 0.18 0.18
suneeta reddy 0.15 0.15 0.15 0.15 0.15
wedgewood holdings limite... 1.61 1.61 - 1.61 1.61
wedgewood holidings limit... - - 1.61 - -
apollo hospitals enterpr... - 22.02 - - -
shobana kamineni 0.13 0.13 - - -
apollo hospitals eneterpr... 22.02 - - - -
president of induia 26.00 - - - -
PARTICULARS Jun 2024% Sep 2024% Dec 2024% Mar 2025% Jun 2025%
investors 49.00 49.00 49.00 49.00 49.00
citadel research and solu... 1.31 1.30 1.30 1.30 1.30
emedlife insurance brokin... 1.72 1.72 1.72 1.71 1.71
investor education and pr... - - - - 1.04
llp 0.75 0.68 0.69 0.81 0.85
quant mutual fund- quant ... - - - - 2.61
vanaja sundar iyer 1.66 1.64 1.95 1.95 1.95
investor education and pr... - - - 1.04 -
quant mutual fund - quant... 2.61 2.61 2.61 2.61 -
investor education and pr... - 0.91 1.04 - -
investor education and pr... 0.91 - - - -

Annual Reports

Title Link
Title Link
Annual Report 2023
Annual Report 2022
Annual Report 2021
Annual Report 2020
Annual Report 2019
Annual Report 2018
Annual Report 2017
Annual Report 2017

Ratings & Research Reports

TYPE AGENCY Link
TYPE AGENCY Link
Credit ICRA
Credit ICRA
TYPE AGENCY Link
TYPE AGENCY Link
 No Research reports exist for this company.Report us

Concalls & Presentations

TYPE QUARTER Link
TYPE QUARTER Link
 Currently we do not have any Concall related to this company.Report us
TYPE QUARTER Link
TYPE QUARTER Link
 Currently we do not have any Presentation related to this company.Report us

Company News

Indraprastha Medical Stock Price Analysis and Quick Research Report. Is Indraprastha Medical an attractive stock to invest in?

Stock investing requires careful analysis of financial data to determine a company's true net worth. This is generally done by examining the company's profit and loss account, balance sheet and cash flow statement, which can be time-consuming and cumbersome.

Examining a company's financial ratios is an easier way to determine its performance, which can help to make sense of the overwhelming amount of information in its financial statements. 

Here are a few indispensable ratios that should be a part of every investor’s research process, or, in simpler words, how to analyse Indraprastha Medical. 

  • PE ratio: Price to Earnings ratio, which indicates how much an investor is willing to pay for a share for every rupee of earnings. A general rule of thumb is that shares trading at a low P/E are undervalued (it depends on other factors too). Indraprastha Medical has a PE ratio of 27.3630344812504 which is high and comparatively overvalued.

  • Return on Assets (ROA): Return on Assets measures how effectively a company can earn a return on its investment in assets. In other words, ROA shows how efficiently a company can convert the money used to purchase assets into net income or profits. Indraprastha Medical has ROA of 20.445% which is a good sign for future performance. (Higher values are always desirable.)

  • Current ratio: The current ratio measures a company's ability to pay its short-term liabilities with its short-term assets. A higher current ratio is desirable so that the company could be stable to unexpected bumps in business and economy. Indraprastha Medical has a Current ratio of 2.4125.

  • Return on equity: ROE measures the ability of a firm to generate profits from its shareholders' investments in the company. In other words, the return on equity ratio shows how much profit each rupee of common stockholders’ equity generates. Indraprastha Medical has a ROE of 29.9672%. (Higher is better)

  • Debt to equity ratio: It is a good metric to check out the capital structure along with its performance. Indraprastha Medical has a Debt to Equity ratio of 0 which means that the company has low proportion of debt in its capital.

  • Sales growth: Indraprastha Medical has reported revenue growth of 8.9708% which is poor in relation to its growth and performance. 

  • Operating Margin: This will tell you about the operational efficiency of the company. The operating margin of Indraprastha Medical for the current financial year is 18.0092305877496%.

  • Dividend Yield: It tells us how much dividend we will receive in relation to the price of the stock. The current year dividend for Indraprastha Medical is Rs 4.5 and the yield is 0.9015%.

  • Earnings Per Share: It tells us how much profit is allocated to to each outstanding share of a common stock. The latest EPS of Indraprastha Medical is Rs 18.2911. The higher the EPS, the better it is for investors. 

One can find all the Financial Ratios of Indraprastha Medical in Ticker for free. Also, one can get the intrinsic value of Indraprastha Medical by using Valuation Calculators, which are available with a Finology ONE subscription. 

Indraprastha Medical FAQs

Q1. What is Indraprastha Medical share price today?
Ans: The current share price of Indraprastha Medical is Rs 500.5.

Q2. What is the market capitalisation of Indraprastha Medical?
Ans: Indraprastha Medical has a market capitalisation of Rs 4588.23365 Cr., calculated based on its latest share price.

Q3. What are the P/E and P/B ratios of Indraprastha Medical?
Ans: The PE ratio of Indraprastha Medical is 27.3630344812504 and the P/B ratio of Indraprastha Medical is 7.07904771603472, showing how the stock is valued against its earnings and book value.

Q4. What is the 52-week high and low of Indraprastha Medical share?
Ans: The 52-week high share price of Indraprastha Medical is Rs 572, and the 52-week low share price of Indraprastha Medical is Rs 307.25.

Q5. Does Indraprastha Medical pay dividends?
Ans: Currently, Indraprastha Medical pays dividends. Dividend yield of Indraprastha Medical is around 0.9015%.

Q6. What are the face value and book value of Indraprastha Medical shares?
Ans: The face value of Indraprastha Medical shares is Rs 10, while the book value per share of Indraprastha Medical is around Rs 70.7016. Face value is the nominal value set by the company, whereas book value reflects its accounting worth.

Q7. What is the debt of Indraprastha Medical?
Ans: Indraprastha Medical has a total debt of Rs 0 Cr., which affects investor sentiment and financial stability. 

Q8. What are the ROE and ROCE of Indraprastha Medical?
Ans: The ROE of Indraprastha Medical is 29.9672% and ROCE of Indraprastha Medical is 41.4337%. ROE shows how efficiently the company is generating profit from shareholders’ equity, while the ROCE is reflects how efficiently the company uses its capital to generate returns.

Q9. Is Indraprastha Medical a good buy for the long term?
Ans: The Indraprastha Medical long-term outlook depends on debt levels, earnings growth, and sector trends. If it sustains profits and manages debt well, it may be considered for long-term investment.

Q10. Is Indraprastha Medical undervalued or overvalued?
Ans: Based on valuation ratios like P/E, P/B, and EV/EBITDA, one can analyse whether the Indraprastha Medical appears undervalued or overvalued at current levels. You can check detailed valuation metrics and peer comparisons on Finology Ticker.

Q11. How to check Indraprastha Medical’s financials?
Ans: You can review Indraprastha Medical’s financial statements - including balance sheet, income statement, and quarterly results - on Finology Ticker.

Last Updated on:
Brief about Indraprastha Medical
X